238 related articles for article (PubMed ID: 15251942)
1. Molecular serological diagnosis in transitional cell bladder cancer.
von Knobloch R; Brandt H; Hofmann R
Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
[TBL] [Abstract][Full Text] [Related]
2. Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.
von Knobloch R; Hegele A; Brandt H; Olbert P; Heidenreich A; Hofmann R
Int J Cancer; 2001 Oct; 94(1):67-72. PubMed ID: 11668480
[TBL] [Abstract][Full Text] [Related]
3. Molecular serological detection of DNA alterations in transitional cell carcinoma is highly sensitive and stage independent.
von Knobloch R; Brandt H; Schrader AJ; Heidenreich A; Hofmann R
Clin Cancer Res; 2004 Feb; 10(3):988-93. PubMed ID: 14871977
[TBL] [Abstract][Full Text] [Related]
4. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
Turyn J; Matuszewski M; Schlichtholz B
Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
[TBL] [Abstract][Full Text] [Related]
7. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
[TBL] [Abstract][Full Text] [Related]
9. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.
Dal Canto M; Bartoletti R; Travaglini F; Piazzini M; Lodovichi G; Rizzo M; Selli C
Anticancer Res; 2003; 23(6D):5095-100. PubMed ID: 14981972
[TBL] [Abstract][Full Text] [Related]
10. Use of polymerase chain reaction analysis of urinary DNA to detect bladder carcinoma.
Little B; Hughes A; Young MR; O'Brien A
Urol Oncol; 2005; 23(2):102-7. PubMed ID: 15869994
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
[TBL] [Abstract][Full Text] [Related]
12. High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis.
von Knobloch R; Hegele A; Brandt H; Varga Z; Wille S; Kälble T; Heidenreich A; Hofmann R
Int J Cancer; 2002 Apr; 98(6):889-94. PubMed ID: 11948468
[TBL] [Abstract][Full Text] [Related]
13. Allelotype of human bladder cancer.
Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
15. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
[TBL] [Abstract][Full Text] [Related]
16. New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladder.
Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
Anticancer Res; 2004; 24(3a):1733-6. PubMed ID: 15274348
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer.
Utting M; Werner W; Dahse R; Schubert J; Junker K
Clin Cancer Res; 2002 Jan; 8(1):35-40. PubMed ID: 11801538
[TBL] [Abstract][Full Text] [Related]
18. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
Szarvas T
Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of preoperative molecular serum analysis in renal cancer.
Gonzalgo ML; Eisenberger CF; Lee SM; Trock BJ; Marshall FF; Hortopan S; Sidransky D; Schoenberg MP
Clin Cancer Res; 2002 Jun; 8(6):1878-81. PubMed ID: 12060631
[TBL] [Abstract][Full Text] [Related]
20. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
